NorthWest Biotherapeutics Inc (NWBO)

[highwayman4life]

Just got off the phone with LG....he responded to my email from this am and told me to call him.

He was getting ready to sit down for dinner when I called so I will be calling him back when I get home from a dinner party tonight.

Here is my current questions to ask LG:

-German reimbursement negotiation process, i.e., what is the typical timeline, how does it work, who makes the decision, is there a ratification cycle in German gov't, etc. BSB's comment on getting a ballpark pricing, even if it was a wide range, would also be welcome info. As well, more precise info the ramp of German sites would be welcome.
-Any expectations on revenue from self-pay patients. Q3 should see some of those, as the Dresden site opened in June.
-Comments on the recent AA on Merck's PD-1 drug after only Phase I results vis a vis DCVax-Direct - that is, is NW planning on pursuing AA and if so, how. IMO it seems DCVax-Direct will be on a path to demonstrate superior efficacy to the Merck drug, but with far fewer than the 89 patients in the Melanoma cohort of the Merck drug.
- Any detail on PhIII enrollment status, more precise dates next year for full enrollment, or perhaps easiest for NW to answer, what is the expected time lag from full enrollment to top line results available and why is that the estimate.
-Where do you stand with Prostate trial and are you looking for a partner
-Big Pharma interest level
-Lack of big financial institutional ownership
-Hiring a PR firm and why continue to respond to AF?

Any other input or questions and I will get as much as he is allowed to give me!